Ovarian PRP for Diminished Ovarian Reserve

Description

This prospective double-blinded randomized placebo control study aims to determine if In Vitro Fertilization (IVF) outcomes are improved by ovarian platelet-rich plasma injections (oPRP) for women diagnosed with diminished ovarian reserve (DOR). Women with DOR notoriously have the lowest chance of pregnancy and live birth compared to age-matched peers with a normal or robust ovarian reserve.

Conditions

Diminished Ovarian Reserve

Study Overview

Study Details

Study overview

This prospective double-blinded randomized placebo control study aims to determine if In Vitro Fertilization (IVF) outcomes are improved by ovarian platelet-rich plasma injections (oPRP) for women diagnosed with diminished ovarian reserve (DOR). Women with DOR notoriously have the lowest chance of pregnancy and live birth compared to age-matched peers with a normal or robust ovarian reserve.

Ovarian Platelet-Rich Plasma Injections for Diminished Ovarian Reserve Patients: A Double-Blinded Placebo-Control Trial

Ovarian PRP for Diminished Ovarian Reserve

Condition
Diminished Ovarian Reserve
Intervention / Treatment

-

Contacts and Locations

New York

Generation Next Fertility, New York, New York, United States, 10022

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Clinical diagnosis of diminished ovarian reserve
  • * Clinical diagnosis of poor ovarian response
  • * Women age 35-42
  • * Clinical diagnosis of premature ovarian failure
  • * Clinical diagnosis of menopause.
  • * Under 35 years of age
  • * Over 42 years of age

Ages Eligible for Study

35 Years to 42 Years

Sexes Eligible for Study

FEMALE

Accepts Healthy Volunteers

Yes

Collaborators and Investigators

Generation Next Fertility,

Jesse Hade, MD, PRINCIPAL_INVESTIGATOR, Generation Next Fertility

Study Record Dates

2025-12-31